Fig. 4: Relative importance of biomarkers predicting AD clinical diagnosis. | Communications Biology

Fig. 4: Relative importance of biomarkers predicting AD clinical diagnosis.

From: β-amyloid and tau drive early Alzheimer’s disease decline while glucose hypometabolism drives late decline

Fig. 4

Diagram depicting the relative importance of biomarkers in predicting AD clinical diagnosis (predictability). In early AD, Aβ and pTau deposition in the brain have higher relative importance in predicting AD clinical diagnosis. In late disease low glucose uptake in the brain has higher relative importance in predicting AD clinical diagnosis.

Back to article page